1 |
Ma S, Wang J, Lu Z, Shi C, Yang D, Lin J. Plexiform fibromyxoma: a clinicopathological and immunohistochemical analysis of two cases with a literature review. J Int Med Res 2021;49:3000605211027878. [PMID: 34369189 DOI: 10.1177/03000605211027878] [Reference Citation Analysis]
|
2 |
Arslan ME, Li H, Fu Z, Jennings TA, Lee H. Plexiform fibromyxoma: Review of rare mesenchymal gastric neoplasm and its differential diagnosis. World J Gastrointest Oncol 2021; 13(5): 409-423 [PMID: 34040702 DOI: 10.4251/wjgo.v13.i5.409] [Reference Citation Analysis]
|
3 |
Yan C, Zhao C, Yang K, Zhou H, Jing L, Zhao W, Dou W, Xia Q, Ma J, Wei B, Guo Y. Rare c-KIT c.1926delA and c.1936T>G Mutations in Exon 13 Define Imatinib Resistance in Gastrointestinal Stromal Tumors and Melanoma Patients: Case Reports and Cell Experiments. Front Mol Biosci 2022;9:730213. [DOI: 10.3389/fmolb.2022.730213] [Reference Citation Analysis]
|
4 |
Zhang R, Xia LG, Huang KB, Chen ND. Huge gastric plexiform fibromyxoma presenting as pyemia by rupture of tumor: A case report. World J Clin Cases 2022; 10(7): 2253-2260 [DOI: 10.12998/wjcc.v10.i7.2253] [Reference Citation Analysis]
|